Vertex Pharmaceuticals just added more than $6b to its market cap after the announcement of a phase II trial result.
Will BOTA have the similar outcome when it announces positive Lani phase II trial result or Vapendavir phase III result (suppose biota goes with it alone)?
answer from hershel, page-5
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)